Cue Health Analysis
Cue Health is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Cue Health delisted stock analysis is to determine its intrinsic value, which is an estimate of what Cue Health is worth, separate from its market price. There are two main types of Cue Health's stock analysis: fundamental analysis and technical analysis.
The Cue Health stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Cue Health's ongoing operational relationships across important fundamental and technical indicators.
Cue |
Cue Stock Analysis Notes
About 53.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 0.1. Some equities with similar Price to Book (P/B) outperform the market in the long run. Cue Health has Price/Earnings To Growth (PEG) ratio of 0.52. The entity recorded a loss per share of 2.13. The firm had not issued any dividends in recent years. Cue Health Inc., a healthcare technology company, designs and develops diagnostic platform for diagnostic tests for individuals, enterprises, healthcare providers and payors, and public health agencies. Cue Health Inc. was incorporated in 2010 and is headquartered in San Diego, California. Cue Health operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 1585 people. To learn more about Cue Health call the company at 858 412 8151 or check out https://www.cuehealth.com.Cue Health Investment Alerts
Cue Health is not yet fully synchronised with the market data | |
Cue Health has some characteristics of a very speculative penny stock | |
Cue Health has a very high chance of going through financial distress in the upcoming years | |
The company reported the previous year's revenue of 70.94 M. Net Loss for the year was (373.46 M) with loss before overhead, payroll, taxes, and interest of (17.95 M). | |
Cue Health currently holds about 363.12 M in cash with (137.81 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.45. |
Cue Health Upcoming and Recent Events
Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Cue Health previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
20th of March 2024 Upcoming Quarterly Report | View | |
8th of May 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
20th of March 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Cue Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 6.9 M.Cue Health Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Cue Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Cue Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Cue Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Cue Health Outstanding Bonds
Cue Health issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Cue Health uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Cue bonds can be classified according to their maturity, which is the date when Cue Health has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Dana 575 percent Corp BondUS235822AB96 | View | |
Volcan Compania Minera Corp BondUSP98047AC08 | View | |
Boeing Co 2196 Corp BondUS097023DG73 | View | |
HSBC Holdings PLC Corp BondUS404280DR76 | View | |
MPLX LP 4875 Corp BondUS55336VAG59 | View | |
MPLX LP 52 Corp BondUS55336VAL45 | View | |
International Game Technology Corp BondUS460599AD57 | View | |
BNP Paribas FRN Corp BondUSF1R15XK367 | View |
Cue Health Technical and Predictive Indicators
Risk Adjusted Performance | (0.12) | |||
Market Risk Adjusted Performance | 1.25 | |||
Mean Deviation | 9.64 | |||
Coefficient Of Variation | (586.07) | |||
Standard Deviation | 16.77 | |||
Variance | 281.28 | |||
Information Ratio | (0.18) | |||
Jensen Alpha | (2.64) | |||
Total Risk Alpha | (5.06) | |||
Treynor Ratio | 1.24 | |||
Maximum Drawdown | 112.25 | |||
Value At Risk | (29.77) | |||
Potential Upside | 24.48 | |||
Skewness | (1.10) | |||
Kurtosis | 8.05 |
Risk Adjusted Performance | (0.12) | |||
Market Risk Adjusted Performance | 1.25 | |||
Mean Deviation | 9.64 | |||
Coefficient Of Variation | (586.07) | |||
Standard Deviation | 16.77 | |||
Variance | 281.28 | |||
Information Ratio | (0.18) | |||
Jensen Alpha | (2.64) | |||
Total Risk Alpha | (5.06) | |||
Treynor Ratio | 1.24 | |||
Maximum Drawdown | 112.25 | |||
Value At Risk | (29.77) | |||
Potential Upside | 24.48 | |||
Skewness | (1.10) | |||
Kurtosis | 8.05 |
About Cue Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Cue Health prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Cue shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as Cue Health. By using and applying Cue Stock analysis, traders can create a robust methodology for identifying Cue entry and exit points for their positions.
Cue Health Inc., a healthcare technology company, designs and develops diagnostic platform for diagnostic tests for individuals, enterprises, healthcare providers and payors, and public health agencies. Cue Health Inc. was incorporated in 2010 and is headquartered in San Diego, California. Cue Health operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 1585 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Cue Health to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Efficient Frontier Now
Efficient FrontierPlot and analyze your portfolio and positions against risk-return landscape of the market. |
All Next | Launch Module |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Cue Stock
If you are still planning to invest in Cue Health check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cue Health's history and understand the potential risks before investing.
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |